As part of the university's commitment to economic development and outreach, CTL hosts a variety of events to create connections between the Cornell campuses, industry members, entrepreneurs, and investors.
TTS North America SummitWeill Cornell Medicine Campus | Belfer Research Building, Room 302
July 24-25, 2017
413 E. 69th Street | New York, NY
Open to: High level leaders and decision-makers from all key stakeholder groups in early stage biotech innovation
TTS North America, part of the TTS Global Initiative, is being held in conjunction with the Center for Technology Licensing on July 24-25, 2017 on the Weill Cornell Medicine Campus in New York, NY.
The event will include mix of keynotes, briefings, open panel discussions, and networking and business development opportunities.
Speakers will include representation from:
Lilly, Pfizer, Versant, Moelis & Company, Tekla Capital Partners, NIH, Bird&Bird, MBHB, Needham&Co, Imperial Innovations, UCLA, Weill Cornell Medicine, and Columbia, amongst others.
Attendance benefits all those working in early-stage development including:
• Start-up executives
• Business development executives
• C-level biotechnology / pharmaceutical executives
• Principal investigators
• Officers from academic institutions
This event is limited to 150 attendees.
Industry Registration: $499
Academic and Early-Stage Company Registration: $299
*$100 Early Bird Discount available thru June 16, 2017.